
See how these top medical tourism destinations compare for Ovarian Cancer Treatment.
| Comparison Factor | Italy | Thailand | Winner |
|---|---|---|---|
| Average Cost (in USD) | 15000 - 35000 | 6000 - 38000 | Thailand |
| Success Rate (Min and Max) | 65% – 88% | 75% – 90% | Thailand |
| Advanced Technology | Advanced gynecologic oncology surgery, robotic and laparoscopic tumour debulking, PET-CT imaging, molecular testing (BRCA/HRD), HIPEC therapy, and targeted therapy programs in specialised cancer centres. | Advanced oncology programs, robotic-assisted cancer surgery, targeted therapy, immunotherapy, and precision diagnostics. | Both Equal |
| JCI Accredited Hospitals | 15+ | 20+ | Thailand |
| Visa Process | Schengen Medical Visa | Medical Visa / Tourist Visa | Both Equal |
*Costs are estimates and may vary based on hospital, complexity, and package inclusions. See detailed cost breakdown below
Understand exactly where your money goes. Both countries offer all-inclusive packages, but here's how the costs typically break down.
Best for Budget-Conscious Patients
Offered Package Price (Additional Cost Excluded)
Best for Flexible Donor Requirements
Offered Package Price (Additional Cost Excluded)
Top Hospitals: Bangkok Hospital , Bangpakok 9 International Hospital , Phyathai 2 International Hospital
Want a personalized cost estimate based on your specific condition?
Get Your Free QuoteBoth Italy and Thailand maintain world-class healthcare standards with internationally accredited hospitals and highly trained medical professionals.
Hospitals in Italy operate under strict European Union healthcare regulations and the Italian National Health Service, with internationally recognised oncology institutes and gynecologic cancer centres.
Treatment outcomes depend on cancer stage, tumour biology, and completeness of tumour debulking. Italian cancer centres follow international oncology protocols aligned with NCCN and ESMO guidelines.
Cancer care in Italy follows EU medical regulations and national oncology protocols ensuring strict chemotherapy safety standards and multidisciplinary cancer treatment planning.
20+ JCI-accredited hospitals regulated by the Thailand Ministry of Public Health with internationally recognized oncology programs.
Strong outcomes in specialized cancer centers using multidisciplinary tumor board approaches with success rates ranging 75–90% depending on stage and treatment type.
Governed by the Thailand Medical Council and Ministry of Public Health, ensuring adherence to international oncology treatment standards
| Quality Metric | Italy | Thailand |
|---|---|---|
Accredited Hospitals | 15+ | 20+ |
Average Success Rate | Yes | 78–85% |
Post-op Survival (1 Year) | Available | - |
Top Speciality Hospital Hubs | Milan, Rome, Bologna | - |
Both countries have highly qualified and experienced medical specialists trained at premier institutions worldwide. Here's what sets them apart.
Gynecologic oncologists specialising in ovarian cancer surgery, cytoreductive tumour debulking, HIPEC therapy, and chemotherapy protocols.
High-volume oncology centres with multidisciplinary tumour boards managing complex gynecologic cancers.
Gynecologic oncologists specializing in ovarian cancer surgery, cytoreductive surgery, and advanced chemotherapy protocols.
Moderate-to-high volumes in comprehensive cancer centers with specialized gynecologic oncology departments.
All surgeons listed on Medigence are verified for their medical license, board certifications, hospital affiliations, and patient outcomes. We conduct background checks and regularly update our database to ensure you're connected with the best medical professionals.
Beyond medical excellence, your comfort during treatment matters. Compare the patient experience at top hospitals in both destinations.

World-class hospitals, exceptional value
Hospitals in Italy have comprehensive cancer centres with advanced surgical theatres, robotic surgery systems, and specialised gynecologic oncology departments. Facilities include radiation oncology units, advanced imaging (CT, MRI, PET-CT), specialised pathology laboratories, and oncology ICUs to support complex cancer surgery and chemotherapy treatments.

Luxury healthcare experience
Advanced oncology operating rooms
Robotic and minimally invasive cancer surgery technology
Dedicated cancer treatment and chemotherapy units
Advanced imaging and molecular diagnostics
Multidisciplinary oncology care programs
Plan your medical journey with confidence. Here's everything you need to know about travel, visas, and accommodation in both countries.
We provide end-to-end travel assistance including visa facilitation, airport pickups, hotel bookings near your hospital, and local support throughout your stay. Our patient coordinators handle all logistics so you can focus on recovery.
Understanding the recovery process helps you plan better. Here's what to expect after Ovarian Cancer Treatment in both countries.
Patients may undergo surgery followed by chemotherapy or targeted therapy, depending on the cancer stage and tumour spread.
Close monitoring occurs in the hospital immediately after surgery, before moving to the recovery wards.
Regular oncology consultations and chemotherapy cycles are scheduled after surgery.
Long-term surveillance includes periodic imaging, CA-125 blood tests, and oncology follow-up visits.
In-person follow-ups recommended at 3, 6, 12 months. Telemedicine available.
Modern oncology ICU and recovery units
Chemotherapy and targeted therapy monitoring
Nutrition and supportive cancer care
Remote follow-up and teleconsultation available
Comprehensive telemedicine follow-up program. Return visits at 6, 12 months if possible.
Ovarian Cancer Treatment recipients require lifelong immunosuppressant medications. Ensure you have a plan for obtaining these medications and regular blood monitoring in your home country before traveling abroad for surgery.
Every medical procedure carries risks. We believe in complete transparency so you can make a fully informed decision about your Ovarian Cancer Treatment journey.
Reduced through sterile surgical environments and advanced postoperative monitoring.
Common after abdominal surgery and managed with medications.
More likely in elderly or advanced-stage cancer patients.
Includes bowel injury, infection, or fluid buildup after surgery.
Chemotherapy may cause fatigue, nausea, hair loss, and reduced immunity.
The right choice depends on your specific situation. Here's a clear guide to help you decide which destination aligns with your needs.
Women diagnosed with early-stage or advanced ovarian cancer requiring surgery, chemotherapy, targeted therapy, or comprehensive cancer care in specialised oncology centres with multidisciplinary treatment teams.
Patients diagnosed with early or advanced-stage ovarian cancer requiring surgery, chemotherapy, or targeted therapy, seeking advanced oncology care, multidisciplinary treatment planning, and comprehensive cancer support programs.
Our medical tourism experts can analyze your case and recommend the best destination based on your medical history and budget.
Follow this step-by-step framework to make the right choice for your Ovarian Cancer Treatment journey.
Treatment planning depends on cancer stage, tumour spread, and the patient's health condition.
Prepare a comprehensive budget including surgery, chemotherapy cycles, hospital stay, travel, and accommodation.
Patients may need to remain locally for several weeks for surgery and initial treatment cycles.
Provide biopsy reports, CT scans, PET-CT scans, and previous oncology treatment records for evaluation.
Regular follow-up imaging, blood tests, and oncology consultations are required after treatment to monitor recovery and detect recurrence.
Let our medical tourism experts guide you through the process. We'll help you:
No obligation • Free consultation • Response within 24 hours

Surgical Oncologist
15 Years of Experience
Dr. Prateek Varshney is a renowned Surgical Oncologist. He has experience of more than 15+ years in surgical Oncology. He is currently practicing as a consultant at Metro Mass Hospital and Cancer Institute. He was also previously associated as a consultant with Sir Ganga Ram Hospital and as a professor at Gujarat Cancer Research Institute. View More